$FRES
Fresh2 Group Ltd Stock $fres

$fres Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 20-F Financial Statement

#000121390023040488 Filed on May 16, 2023

Income Statement

Concept	2022 Q4	2022	2021 Q4
Revenue	$440.0K	$1.746M	$4.306M
YoY Change	-89.78%	-90.29%	-73.84%
Cost Of Revenue	$470.0K	$538.0K	$165.0K
YoY Change	184.85%	-90.61%	-96.95%
Gross Profit	-$30.00K	$1.208M	$4.141M
YoY Change	-100.72%	-90.14%	-62.49%
Gross Profit Margin	-6.82%	69.19%	96.17%
Selling, General & Admin	$30.32M	$12.03M	$25.84M
YoY Change	17.36%	-88.22%	-33.86%
% of Gross Profit		995.45%	623.88%
Research & Development	$1.610M	$1.381M	$4.341M
YoY Change	-62.91%	-91.48%	4.86%
% of Gross Profit		114.32%	104.83%
Depreciation & Amortization		$682.0K	$2.509M
YoY Change		-82.56%	58.1%
% of Gross Profit		56.46%	60.59%
Operating Expenses	$31.94M	$13.41M	$30.18M
YoY Change	5.85%	-88.67%	-30.25%
Operating Profit	-$31.97M	-$15.20M	-$26.04M
YoY Change	22.8%	-85.67%	-19.2%
Interest Expense	$430.0K	$34.00K	$60.00K
YoY Change	616.67%	-100.79%	-90.48%
% of Operating Profit
Other Income/Expense, Net	-$920.0K	$565.0K	-$3.418M
YoY Change	-73.08%	-106.99%	-140.35%
Pretax Income	-$32.46M	-$15.33M	-$32.20M
YoY Change	0.79%	-87.36%	31.23%
Income Tax	$0.00	-$309.0K	-$1.069M
% Of Pretax Income
Net Earnings	-$31.90M	-$14.77M	-$31.11M
YoY Change	2.55%	-87.55%	27.39%
Net Earnings / Revenue	-7250.0%	-846.05%	-722.43%
Basic Earnings Per Share		-$0.39
Diluted Earnings Per Share	-$0.48	-$2.66	-$2.203M
COMMON SHARES
Basic Shares Outstanding		38.24M shares
Diluted Shares Outstanding		38.24M shares

Balance Sheet

Concept	2022 Q4	2022	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.900M	$1.870M	$9.251M
YoY Change	-79.46%	-79.79%	206.32%
Cash & Equivalents	1.870M cnies	$1.870M	$9.251M
Short-Term Investments
Other Short-Term Assets	$500.0K	$5.490M	$1.497M
YoY Change	-66.6%	266.73%	-54.64%
Inventory	$30.00K	$210.0K	$490.0K
Prepaid Expenses	$543.0K		4.704M cnies
Receivables	$324.0K	$2.240M	$5.554M
Other Receivables	$500.0K	$3.890M	$6.757M
Total Short-Term Assets	$1.986M	$13.70M	$23.55M
YoY Change	-91.57%	-41.82%	10.61%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.491M	$24.40M	$20.26M
YoY Change	-87.71%	20.41%	5.16%
Goodwill			12.76M cnies
YoY Change
Intangibles	$1.439M
YoY Change
Long-Term Investments	$1.100M	$1.080M	$923.0K
YoY Change	19.18%	17.01%	4.89%
Other Assets	$1.100M	$1.110M	$0.00
YoY Change			-100.0%
Total Long-Term Assets	$3.881M	$26.77M	$43.94M
YoY Change	-91.17%	-39.08%	53.64%
TOTAL ASSETS
Total Short-Term Assets	$1.986M	$13.70M	$23.55M
Total Long-Term Assets	$3.881M	$26.77M	$43.94M
Total Assets	$5.867M	$40.47M	$67.49M
YoY Change	-91.31%	-40.03%	35.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$303.0K	$2.110M	$2.732M
YoY Change	-88.91%	-22.77%	28.26%
Accrued Expenses	$25.10M	$25.09M	$17.54M
YoY Change	43.07%	43.01%	-30.79%
Deferred Revenue	$719.0K		4.174M cnies
YoY Change	-82.77%
Short-Term Debt	$727.0K	$5.020M	$33.76M
YoY Change	-97.85%	-85.13%	310.19%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.128M	$42.28M	$62.91M
YoY Change	-90.26%	-32.79%	44.55%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$157.0K	$7.600M	$1.107M
YoY Change	-85.82%	586.54%	-45.74%
Total Long-Term Liabilities	$157.0K	$7.600M	$1.107M
YoY Change	-85.82%	586.54%	-45.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.128M	$42.28M	$62.91M
Total Long-Term Liabilities	$157.0K	$7.600M	$1.107M
Total Liabilities	$7.230M	$54.15M	$71.99M
YoY Change	-89.96%	-24.78%	53.36%
SHAREHOLDERS EQUITY
Retained Earnings	-$83.74M		-475.6M cnies
YoY Change	-82.4%
Common Stock	$797.0K		1.096M cnies
YoY Change	-27.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.595M
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.982M	-$13.68M	-$4.499M
YoY Change
Total Liabilities & Shareholders Equity	$5.867M	$40.47M	$67.49M
YoY Change	-91.31%	-40.03%	35.28%

Cashflow Statement

Concept	2022 Q4	2022	2021 Q4
OPERATING ACTIVITIES
Net Income	-$31.90M	-$14.77M	-$31.11M
YoY Change	2.55%	-87.55%	27.39%
Depreciation, Depletion And Amortization		$682.0K	$2.509M
YoY Change		-82.56%	58.1%
Cash From Operating Activities		-$7.983M	-$43.41M
YoY Change		-88.87%	761.52%
INVESTING ACTIVITIES
Capital Expenditures		$211.0K	-$2.733M
YoY Change		-105.31%	110.07%
Acquisitions
YoY Change
Other Investing Activities			$41.00K
YoY Change			-685.71%
Cash From Investing Activities		-$231.0K	-$2.692M
YoY Change		-94.13%	105.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00	$18.44M
YoY Change		-100.0%	-354.86%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$7.173M	48.47M
YoY Change		-91.4%	2279.68%
NET CHANGE
Cash From Operating Activities		-$7.983M	-43.41M
Cash From Investing Activities		-$231.0K	-2.692M
Cash From Financing Activities		$7.173M	48.47M
Net Change In Cash		-$1.070M	2.370M
YoY Change		-113.75%	-154.99%
FREE CASH FLOW
Cash From Operating Activities		-$7.983M	-$43.41M
Capital Expenditures		$211.0K	-$2.733M
Free Cash Flow		-$8.194M	-$40.68M
YoY Change		-87.9%	988.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8174000	cny
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10172000	cny
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1475000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-105728000	cny
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15328000	usd
CY2022	dei	Document Type DocumentType	20-F
CY2022	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39137
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D8
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	650 5TH AVE STE 2416
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	NEW YORK, NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10019-6108
CY2022	dei	Entity Address Country EntityAddressCountry	US
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Auditor Firm AuditorFirmId	5395
CY2022	dei	Auditor Name AuditorName	Marcum Asia CPAs llp
CY2022	dei	Auditor Location AuditorLocation	New York, New York
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9251000	cny
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1870000	cny
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	271000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4704000	cny
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3742000	cny
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	543000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5554000	cny
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2235000	cny
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	324000	usd
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	200000	cny
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	2194000	cny
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	318000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	490000	cny
CY2022Q4	us-gaap	Inventory Net InventoryNet	210000	cny
CY2022Q4	us-gaap	Inventory Net InventoryNet	30000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3350000	cny
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	3448000	cny
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	500000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	23549000	cny
CY2022Q4	us-gaap	Assets Current AssetsCurrent	13699000	cny
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1986000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20264000	cny
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	17182000	cny
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2491000	usd
CY2021Q4	anpc	Land Use Rights Net LandUseRightsNet	1138000	cny
CY2022Q4	anpc	Land Use Rights Net LandUseRightsNet	1111000	cny
CY2022Q4	anpc	Land Use Rights Net LandUseRightsNet	161000	usd
CY2021Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	8857000	cny
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	185000	cny
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	27000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	12758000	cny
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7213000	cny
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1046000	usd
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	923000	cny
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	1079000	cny
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	156000	usd
CY2021Q4	us-gaap	Assets Assets	67489000	cny
CY2022Q4	us-gaap	Assets Assets	40469000	cny
CY2022Q4	us-gaap	Assets Assets	5867000	usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	33759000	cny
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	5015000	cny
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	727000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2732000	cny
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2108000	cny
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	303000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4174000	cny
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4956000	cny
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	719000	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	2471000	cny
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	3494000	cny
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	507000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	784000	cny
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	114000	usd
CY2021Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	19770000	cny
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	25921000	cny
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	3758000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	62906000	cny
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	42278000	cny
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6128000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2158000	cny
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6515000	cny
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	945000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1107000	cny
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1080000	cny
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	157000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	66171000	cny
CY2022Q4	us-gaap	Liabilities Liabilities	49873000	cny
CY2022Q4	us-gaap	Liabilities Liabilities	7230000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1096000	cny
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	5494000	cny
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	797000	usd
CY2021Q4	anpc	Common Stock Value1 CommonStockValue1	185000	cny
CY2022Q4	anpc	Common Stock Value1 CommonStockValue1	240000	cny
CY2022Q4	anpc	Common Stock Value1 CommonStockValue1	35000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	11003000	cny
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1595000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	465334000	cny
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	564869000	cny
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	81898000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-475646000	cny
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-577539000	cny
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-83735000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4532000	cny
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4263000	cny
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	618000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4499000	cny
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-13676000	cny
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1982000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	5817000	cny
CY2022Q4	us-gaap	Minority Interest MinorityInterest	4272000	cny
CY2022Q4	us-gaap	Minority Interest MinorityInterest	619000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1318000	cny
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9404000	cny
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1363000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	67489000	cny
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40469000	cny
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5867000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20373000	cny
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16581000	cny
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2223000	cny
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9849000	cny
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1428000	usd
CY2020	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	136000	cny
CY2021	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	1405000	cny
CY2022	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	2195000	cny
CY2022	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	318000	usd
CY2020	us-gaap	Revenues Revenues	20509000	cny
CY2021	us-gaap	Revenues Revenues	17986000	cny
CY2022	us-gaap	Revenues Revenues	12044000	cny
CY2022	us-gaap	Revenues Revenues	1746000	usd
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	7628000	cny
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	5732000	cny
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	3708000	cny
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	538000	usd
CY2020	us-gaap	Gross Profit GrossProfit	12881000	cny
CY2021	us-gaap	Gross Profit GrossProfit	12254000	cny
CY2022	us-gaap	Gross Profit GrossProfit	8336000	cny
CY2022	us-gaap	Gross Profit GrossProfit	1208000	usd
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	19674000	cny
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	21420000	cny
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	12154000	cny
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1762000	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11576000	cny
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16204000	cny
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9532000	cny
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1381000	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	74757000	cny
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	80676000	cny
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	70788000	cny
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10263000	usd
CY2020	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	1430000	cny
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3828000	cny
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	7911000	cny
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1147000	usd
CY2020	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	2706000	cny
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	17762000	cny
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	34167000	cny
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	14924000	cny
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2164000	usd
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	7162000	cny
CY2020	anpc	Fair Value Loss On Convertible Loan FairValueLossOnConvertibleLoan	532000	cny
CY2021	anpc	Fair Value Loss On Convertible Loan FairValueLossOnConvertibleLoan	9073000	cny
CY2022	anpc	Fair Value Loss On Convertible Loan FairValueLossOnConvertibleLoan	-144000	cny
CY2022	anpc	Fair Value Loss On Convertible Loan FairValueLossOnConvertibleLoan	-21000	usd
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	36000	cny
CY2020	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	1430000	cny
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-88000	cny
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1180000	cny
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2158000	cny
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-313000	usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	3828000	cny
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	7911000	cny
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1147000	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2223000	cny
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	12758000	cny
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1850000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	794000	cny
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	115000	usd
CY2021	anpc	Forgivenesses Of Ppp Loan ForgivenessesOfPPPLoan	905000	cny
CY2020	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	4775000	cny
CY2021	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	-786000	cny
CY2022	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	-1207000	cny
CY2022	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	-175000	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7256000	cny
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1539000	cny
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2896000	cny
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-420000	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	44000	cny
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	180000	cny
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-285000	cny
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-41000	usd
CY2020	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	219000	cny
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-240000	cny
CY2021	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-215000	cny
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	441000	cny
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	64000	usd
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-4845000	cny
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1056000	cny
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	68000	cny
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	10000	usd
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-502000	cny
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	350000	cny
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	360000	cny
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-626000	cny
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-91000	usd
CY2020	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	128000	cny
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-131000	cny
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-19000	usd
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1232000	cny
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	107000	cny
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	781000	cny
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	113000	usd
CY2020	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	6825000	cny
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-1875000	cny
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	5506000	cny
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	798000	usd
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	519000	cny
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-924000	cny
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-27000	cny
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-4000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	12758000	cny
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1850000	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-94556000	cny
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-112097000	cny
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-104807000	cny
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-15195000	usd
CY2020	us-gaap	Noninterest Expense NoninterestExpense	1143000	cny
CY2021	us-gaap	Noninterest Expense NoninterestExpense	4257000	cny
CY2022	us-gaap	Noninterest Expense NoninterestExpense	373000	cny
CY2022	us-gaap	Noninterest Expense NoninterestExpense	54000	usd
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-667000	cny
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-202000	cny
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-787000	cny
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-114000	usd
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-13000	cny
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	132000	cny
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	156000	cny
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	23000	usd
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	9096000	cny
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	990000	cny
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-61000	cny
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9000	usd
CY2021	anpc	Gain From A Step Acquisition GainFromAStepAcquisition	3240000	cny
CY2020	anpc	Change In Fair Value Of Convertible Debt ChangeInFairValueOfConvertibleDebt	-6630000	cny
CY2021	anpc	Change In Fair Value Of Convertible Debt ChangeInFairValueOfConvertibleDebt	9073000	cny
CY2022	anpc	Change In Fair Value Of Convertible Debt ChangeInFairValueOfConvertibleDebt	-144000	cny
CY2022	anpc	Change In Fair Value Of Convertible Debt ChangeInFairValueOfConvertibleDebt	-21000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-80653000	cny
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		cny
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-121267000	cny
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-105728000	cny
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15328000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		cny
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-88000	cny
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1180000	cny
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2130000	cny
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-309000	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue		cny
CY2020	us-gaap	Profit Loss ProfitLoss	-80565000	cny
CY2021	us-gaap	Profit Loss ProfitLoss	-120087000	cny
CY2022	us-gaap	Profit Loss ProfitLoss	-103598000	cny
CY2022	us-gaap	Profit Loss ProfitLoss	-15019000	usd
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-90000	cny
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1392000	cny
CY2021	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		cny
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1705000	cny
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-247000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-80475000	cny
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-118695000	cny
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		cny
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-101893000	cny
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-14772000	usd
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.19
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.72
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.66
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.39
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11190079	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13605515	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38242073	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38242073	shares
CY2020	anpc	Fair Value Change Relating To Companys Own Credit Risk On Convertible Loan FairValueChangeRelatingToCompanysOwnCreditRiskOnConvertibleLoan	-108000	cny
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		cny
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2793000	cny
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-263000	cny
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-269000	cny
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-39000	usd
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		cny
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-77880000	cny
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-120350000	cny
CY2020	anpc	Gain From A Step Acquisition GainFromAStepAcquisition		cny
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-103867000	cny
CY2022	anpc	Gain From A Step Acquisition GainFromAStepAcquisition		cny
CY2022	anpc	Gain From A Step Acquisition GainFromAStepAcquisition		usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-15058000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-90000	cny
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1392000	cny
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1705000	cny
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.39
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.66
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-247000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-77790000	cny
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-118958000	cny
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.19
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-102162000	cny
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-8.72
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14811000	usd
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11190079	shares
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-15924000	cny
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13605515	shares
CY2020	us-gaap	Profit Loss ProfitLoss	-80565000	cny
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38242073	shares
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	75460000	cny
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38242073	shares
CY2020	anpc	Stock Issued During Period Value Stock Options Exercised1 StockIssuedDuringPeriodValueStockOptionsExercised1	783000	cny
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2706000	cny
CY2020	us-gaap	Adjustments To Additional Paid In Capital Mark To Market AdjustmentsToAdditionalPaidInCapitalMarkToMarket	-108000	cny
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	2793000	cny
CY2020	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	370000	cny
CY2021	anpc	Fair Value Change Relating To Companys Own Credit Risk On Convertible Loan FairValueChangeRelatingToCompanysOwnCreditRiskOnConvertibleLoan		cny
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	17762000	cny
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3277000	cny
CY2021	us-gaap	Profit Loss ProfitLoss	-120087000	cny
CY2022	anpc	Fair Value Change Relating To Companys Own Credit Risk On Convertible Loan FairValueChangeRelatingToCompanysOwnCreditRiskOnConvertibleLoan		cny
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	6880000	cny
CY2022	anpc	Fair Value Change Relating To Companys Own Credit Risk On Convertible Loan FairValueChangeRelatingToCompanysOwnCreditRiskOnConvertibleLoan		usd
CY2021	anpc	Issuance Of Shares In Private Placements Net Of Offering Costs IssuanceOfSharesInPrivatePlacementsNetOfOfferingCosts	49242000	cny
CY2021	anpc	Stock Issued During Period Value Stock Options Exercised1 StockIssuedDuringPeriodValueStockOptionsExercised1	7992000	cny
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	20110000	cny
CY2020	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss		cny
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	34167000	cny
CY2022	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss		cny
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-263000	cny
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1318000	cny
CY2022	us-gaap	Profit Loss ProfitLoss	-103598000	cny
CY2022	anpc	Issuance Of Shares In Private Placements Net Of Offering Costs IssuanceOfSharesInPrivatePlacementsNetOfOfferingCosts	61012000	cny
CY2022	anpc	Stock Issued During Period Value Stock Options Exercised1 StockIssuedDuringPeriodValueStockOptionsExercised1	313000	cny
CY2022	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss		usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	27739000	cny
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	11003000	cny
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	14924000	cny
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	160000	cny
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-269000	cny
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-9404000	cny
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1363000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-80565000	cny
CY2021	us-gaap	Profit Loss ProfitLoss	-120087000	cny
CY2022	us-gaap	Profit Loss ProfitLoss	-103598000	cny
CY2022	us-gaap	Profit Loss ProfitLoss	-15019000	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3096000	cny
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		cny
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3910000	cny
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4704000	cny
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	682000	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		cny
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-13000	cny
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	132000	cny
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	156000	cny
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	23000	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1203000	cny
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		cny
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		cny
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1897000	cny
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	301000	cny
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	44000	usd
CY2020	anpc	Gain Loss On Disposition Of Land Use Rights GainLossOnDispositionOfLandUseRights	51000	cny
CY2021	anpc	Gain Loss On Disposition Of Land Use Rights GainLossOnDispositionOfLandUseRights	5000	cny
CY2021	us-gaap	Inventory Write Down InventoryWriteDown		cny
CY2022	anpc	Gain Loss On Disposition Of Land Use Rights GainLossOnDispositionOfLandUseRights	933000	cny
CY2022	anpc	Gain Loss On Disposition Of Land Use Rights GainLossOnDispositionOfLandUseRights	135000	usd
CY2021	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	3240000	cny
CY2022	us-gaap	Inventory Write Down InventoryWriteDown		cny
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	88000	cny
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-711000	cny
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-103000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-58967000	cny
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-71709000	cny
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-55060000	cny
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7983000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2466000	cny
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3899000	cny
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1457000	cny
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	211000	usd
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	26000	cny
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	74000	cny
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	135000	cny
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	20000	usd
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	10000	cny
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-41000	cny
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2482000	cny
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3932000	cny
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1592000	cny
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-231000	usd
CY2020	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	13830000	cny
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	38244000	cny
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	5000000	cny
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	725000	usd
CY2020	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	20000000	cny
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	6000000	cny
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	5900000	cny
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	855000	usd
CY2020	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1498000	cny
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	800000	cny
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	116000	usd
CY2020	anpc	Repayments Of Related Party Debts RepaymentsOfRelatedPartyDebts	2570000	cny
CY2021	anpc	Repayments Of Related Party Debts RepaymentsOfRelatedPartyDebts	-6217000	cny
CY2022	anpc	Repayments Of Related Party Debts RepaymentsOfRelatedPartyDebts	640000	cny
CY2022	anpc	Repayments Of Related Party Debts RepaymentsOfRelatedPartyDebts	93000	usd
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8000	cny
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2608000	cny
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	40000	cny
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	11003000	cny
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1595000	usd
CY2020	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	370000	cny
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	160000	cny
CY2022	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	23000	usd
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	42351000	cny
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	61012000	cny
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	8846000	usd
CY2020	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-17261000	cny
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	110668000	cny
CY2020	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	25619000	cny
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	60924000	cny
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	83420000	cny
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	49469000	cny
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7173000	usd
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-2584000	cny
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1544000	cny
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-198000	cny
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-29000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3109000	cny
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6235000	cny
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7381000	cny
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1070000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6125000	cny
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3016000	cny
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9251000	cny
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1341000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3016000	cny
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9251000	cny
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1870000	cny
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	271000	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	2413000	cny
CY2021	us-gaap	Interest Paid Net InterestPaidNet	2187000	cny
CY2022	us-gaap	Interest Paid Net InterestPaidNet	272000	cny
CY2022	us-gaap	Interest Paid Net InterestPaidNet	39000	usd
CY2021	anpc	Issuance Shares For Stock Option Exercised By Dr Chris Chang Yu IssuanceSharesForStockOptionExercisedByDrChrisChangYu	6125000	cny
CY2022	anpc	Issuance Shares For Stock Option Exercised By Dr Chris Chang Yu IssuanceSharesForStockOptionExercisedByDrChrisChangYu	273000	cny
CY2022	anpc	Issuance Shares For Stock Option Exercised By Dr Chris Chang Yu IssuanceSharesForStockOptionExercisedByDrChrisChangYu	40000	usd
CY2021	anpc	Issuance Shares For Related Party Loan IssuanceSharesForRelatedPartyLoan	6891000	cny
CY2021	us-gaap	Stock Issued1 StockIssued1	6880000	cny
CY2021	anpc	Reclassification Of Accounts Payable To Convertible Loan ReclassificationOfAccountsPayableToConvertibleLoan	4534000	cny
CY2021	anpc	Conversion Of Convertible Loans ConversionOfConvertibleLoans	20110000	cny
CY2022	anpc	Conversion Of Convertible Loans ConversionOfConvertibleLoans	27739000	cny
CY2022	anpc	Conversion Of Convertible Loans ConversionOfConvertibleLoans	4022000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8027000	cny
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1164000	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>1. ORGANIZATION AND PRINCIPAL ACTIVITIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Fresh2 Group Limited (Formerly AnPac Bio-Medical Science Co., Ltd., the “Company”) was incorporated in the British Virgin Islands (“the BVI”) in January 2010. The Company and its subsidiaries (collectively, the “Group”) are engaged in one business segment, marketing and selling a multi-cancer screening and detection test that uses innovative, patented cancer differentiation analysis (the “CDA”) technology and proprietary cancer-detection devices, primarily in the People’s Republic of China (the “PRC” or “China”). The Company incorporated a new subsidiary, Fresh2 Technology Inc. (“Fresh2”) on October 4, 2022 and acquired Fresh 2 Ecommerce Inc. (“Fresh2 Ecommerce”) on February 7, 2023. Fresh2 Ecommerce is a business-to-business e-commerce platform focused on connecting Asian food suppliers and supermarkets in the U.S. For the year ended December 31, 2022, the Company did not generate any revenue from this new operation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2022, the details of the Group’s principal subsidiaries are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="background-color: White; text-align: left; width: 40%; vertical-align: top"> </td> <td style="background-color: White; white-space: nowrap; width: 1%"> </td> <td style="background-color: White; text-align: center; white-space: nowrap; width: 10%"><span style="font-size: 10pt"><b>Percentage of</b></span></td> <td style="background-color: White; white-space: nowrap; width: 1%"> </td> <td style="background-color: White; width: 1%"> </td> <td style="background-color: White; text-align: center; white-space: nowrap; width: 13%"><span style="font-size: 10pt"><b>Date of</b></span></td> <td style="background-color: White; white-space: nowrap; width: 1%"> </td> <td style="background-color: White; text-align: center; white-space: nowrap; width: 10%"><span style="font-size: 10pt"><b>Place of<br/> Incorporation/</b></span></td> <td style="background-color: White; white-space: nowrap; width: 1%"> </td> <td style="background-color: White; white-space: nowrap; width: 22%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="background-color: White; border-bottom: Black 1.5pt solid; text-align: left; vertical-align: top"><span style="font-size: 10pt"><b>Major subsidiaries</b></span></td> <td style="background-color: White; padding-bottom: 1.5pt; white-space: nowrap"> </td> <td style="background-color: White; border-bottom: Black 1.5pt solid; text-align: center; white-space: nowrap"><span style="font-size: 10pt"><b>Ownership</b></span></td> <td style="background-color: White; padding-bottom: 1.5pt; white-space: nowrap"> </td> <td style="background-color: White"> </td> <td style="background-color: White; border-bottom: Black 1.5pt solid; text-align: center; white-space: nowrap"><span style="font-size: 10pt"><b>Incorporation</b></span></td> <td style="background-color: White; padding-bottom: 1.5pt; white-space: nowrap"> </td> <td style="background-color: White; border-bottom: Black 1.5pt solid; text-align: center; white-space: nowrap"><span style="font-size: 10pt"><b>Acquisition</b></span></td> <td style="background-color: White; padding-bottom: 1.5pt; white-space: nowrap"> </td> <td style="background-color: White; border-bottom: Black 1.5pt solid; text-align: center; white-space: nowrap"><span style="font-size: 10pt"><b>Major Operation</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top"><span style="font-size: 10pt">Changhe Bio-Medical Technology (Yangzhou) Co., Ltd.</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt">100</span></td> <td style="white-space: nowrap"><span style="font-size: 10pt">%</span></td> <td> </td> <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">March 2010</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">the PRC</span></td> <td style="white-space: nowrap"> </td> <td><span style="font-size: 10pt">Cancer screening and detection tests</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; vertical-align: top"><span style="font-size: 10pt">Changwei System Technology (Shanghai) Co., Ltd.*</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt">100</span></td> <td style="white-space: nowrap"><span style="font-size: 10pt">%</span></td> <td> </td> <td style="text-align: center"><span style="font-size: 10pt">March 2011</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">the PRC</span></td> <td style="white-space: nowrap"> </td> <td><span style="font-size: 10pt">Research and development</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top"><span style="font-size: 10pt">AnPac Bio-Medical Technology (Lishui) Co., Ltd. (“AnPac Lishui”)</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt">100</span></td> <td style="white-space: nowrap"><span style="font-size: 10pt">%</span></td> <td> </td> <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">October 2012</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">the PRC</span></td> <td style="white-space: nowrap"> </td> <td><span style="font-size: 10pt">Cancer screening detection tests and device manufacturing</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; vertical-align: top"><span style="font-size: 10pt">AnPac Bio-Medical Technology (Shanghai) Co., Ltd.</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt">100</span></td> <td style="white-space: nowrap"><span style="font-size: 10pt">%</span></td> <td> </td> <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">April 2014</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">the PRC</span></td> <td style="white-space: nowrap"> </td> <td><span style="font-size: 10pt">Cancer screening and detection tests</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top"><span style="font-size: 10pt">AnPac Technology USA Co., Ltd. (“AnPac US”)</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt">100</span></td> <td style="white-space: nowrap"><span style="font-size: 10pt">%</span></td> <td> </td> <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">September 2015</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">the U.S.</span></td> <td style="white-space: nowrap"> </td> <td><span style="font-size: 10pt">Clinical trials for research on cancer screening and detection tests</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; vertical-align: top"><span style="font-size: 10pt">Lishui AnPac Medical Laboratory Co., Ltd.</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt">100</span></td> <td style="white-space: nowrap"><span style="font-size: 10pt">%</span></td> <td> </td> <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">July 2016</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">the PRC</span></td> <td style="white-space: nowrap"> </td> <td><span style="font-size: 10pt">Cancer screening and detection tests</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; vertical-align: top"><span style="font-size: 10pt">Shiji (Hainan) Medical Technology Ltd.</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt">100</span></td> <td style="white-space: nowrap"><span style="font-size: 10pt">%</span></td> <td> </td> <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">March 2013</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">the PRC</span></td> <td style="white-space: nowrap"> </td> <td><span style="font-size: 10pt">Cancer screening and detection research</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; vertical-align: top"><span style="font-size: 10pt">Shanghai Muqing AnPac Health Technology Co., Ltd. (“AnPac Muqing”)</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt">51</span></td> <td style="white-space: nowrap"><span style="font-size: 10pt">%</span></td> <td> </td> <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">March 2019</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">the PRC</span></td> <td style="white-space: nowrap"> </td> <td><span style="font-size: 10pt">Cancer screening and detection tests</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; white-space: nowrap; vertical-align: top"><span style="font-size: 10pt">Anpai (Shanghai) Healthcare Management and Consulting Co., Ltd.</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: right"><span style="font-size: 10pt">60</span></td> <td style="white-space: nowrap"><span style="font-size: 10pt">%</span></td> <td> </td> <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">August 15, 2021</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-size: 10pt">the PRC</span></td> <td style="white-space: nowrap"> </td> <td style="white-space: nowrap"><span style="font-size: 10pt">Cancer screening and detection tests</span></td></tr> <tr style="background-color: White"> <td style="white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fresh 2 Technology Inc. (“Fresh2”)</span></td> <td style="white-space: nowrap; vertical-align: bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">100</span></td> <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td> <td style="vertical-align: bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">October 4, 2022</span></td> <td style="white-space: nowrap; vertical-align: bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">USA</span></td> <td style="white-space: nowrap; vertical-align: bottom"> </td> <td style="white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B2B e-commerce</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tr style="vertical-align: top"> <td style="font-size: 10pt"></td> <td style="text-align: justify; font-size: 10pt">AnPac Muqing closed business in March 2023 subsequently.</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>*</td> <td style="text-align: justify; font-size: 10pt"><p style="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">On August 2, 2022, the Company’s board passed a preliminary plan to divest Changwei System Technology (Shanghai) Co., Ltd., a subsidiary focusing on research and development. On September 1, 2022, the Company entered into an agreement pursuant to which it agreed to sell its 100% ownership interest in Changwei System Technology (Shanghai) Co., Ltd. to two third parties for RMB365. As of the report date, the disposal of Changwei System Technology (Shanghai) Co., Ltd. was not completed and the Company has not received the payment from the purchasers. This disposition does not represent strategic shift and has no significant effect on the Company’s operations and financial results, therefore, no discontinued operations were presented.</p></td></tr> </table>
CY2022Q3	anpc	Agreement Pursuant Percentage AgreementPursuantPercentage	1	pure
CY2022Q3	us-gaap	Jointly Owned Utility Plant Net Ownership Amount JointlyOwnedUtilityPlantNetOwnershipAmount	365000	cny
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1870000	cny
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	271000	usd
CY2022	anpc	Working Capital Deficit WorkingCapitalDeficit	28579000	cny
CY2022	anpc	Working Capital Deficit WorkingCapitalDeficit	4142000	usd
CY2020	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	80565000	cny
CY2021	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-120087000	cny
CY2022	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	103598000	cny
CY2022	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	-15019000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	58967000	cny
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	71709000	cny
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	55060000	cny
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	7983000	usd
CY2022	anpc	Prefunded Warrant Description PrefundedWarrantDescription	The purchase price of each pre-funded warrant is equal to the price per one ADS, minus $0.0001, and the exercise price of each pre-funded warrant will equal $0.0001 per share. The pre-funded warrants are immediately exercisable and may be exercised at any time until exercised in full. The warrants are immediately exercisable, will expire five (5) years from the original issuance date and have an exercise price of $4.00 per ADS. The Company issued to Univest Securities, LLC (“Univest”), the sole placement agent for the Offering, warrants exercisable for 37,500 ADSs, with an exercise price of $4.80 per ADS (the “Placement Agent Warrants”), pursuant to a placement agency agreement (the “Placement Agency Agreement”) dated March 31, 2023 between the Company and Univest. Other than in respect of the exercise price, the Placement Agent Warrants have terms identical to the pre-funded warrants. The Company received approximately US$3,010 (RMB20,761) from this offering.
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b>(c) Use of estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Areas where management uses subjective judgement include, but are not limited to allowance for doubtful accounts, share-based compensation, deferred tax and uncertain tax position, valuation of convertible loans, useful lives of intangible assets and property and equipment, and impairment of long-lived assets, goodwill and long-term investments. Changes in facts and circumstances may result in revised estimates. Actual results could differ from those estimates, and as such, differences could be material to the consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2022	anpc	Estimated Useful Life EstimatedUsefulLife	Over the shorter of the lease term or estimated useful lives
CY2020	anpc	Recognized An Impairment On Its Equity Investment RecognizedAnImpairmentOnItsEquityInvestment	1430000	cny
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	2223000	usd
CY2022	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax	12758000	cny
CY2022	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax	1850000	usd
CY2022	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	7911000	cny
CY2022	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	1147000	usd
CY2021Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	27859000	cny
CY2022Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	15000	cny
CY2022Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	2000	usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	2232000	cny
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	27859000	cny
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	4039000	usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	32344000	cny
CY2021	anpc	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Conversion Of Accounts Payable Issuances FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfAccountsPayableIssuances	4534000	cny
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	-20110000	cny
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	-27739000	cny
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	-4022000	usd
CY2021	anpc	Lossgain On Change In Fair Value Of Convertible Loan LossgainOnChangeInFairValueOfConvertibleLoan	9073000	cny
CY2022	anpc	Lossgain On Change In Fair Value Of Convertible Loan LossgainOnChangeInFairValueOfConvertibleLoan	-144000	cny
CY2022	anpc	Lossgain On Change In Fair Value Of Convertible Loan LossgainOnChangeInFairValueOfConvertibleLoan	-21000	usd
CY2021	anpc	Other Comprehensive Incomeforeign Exchange Translations OtherComprehensiveIncomeforeignExchangeTranslations	-214000	cny
CY2022	anpc	Other Comprehensive Incomeforeign Exchange Translations OtherComprehensiveIncomeforeignExchangeTranslations	39000	cny
CY2022	anpc	Other Comprehensive Incomeforeign Exchange Translations OtherComprehensiveIncomeforeignExchangeTranslations	6000	usd
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	27859000	cny
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	15000	cny
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	2000	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.05	pure
CY2020Q4	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	1248000	cny
CY2021Q4	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	330000	cny
CY2022Q4	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	1877000	cny
CY2022Q4	us-gaap	Other Liabilities And Deferred Revenue Noncurrent OtherLiabilitiesAndDeferredRevenueNoncurrent	272000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4174000	cny
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4956000	cny
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	719000	usd
CY2022	anpc	Value Added Tax Percent ValueAddedTaxPercent	0.06	pure
CY2020	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	20509000	cny
CY2021	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	17986000	cny
CY2022	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	12044000	cny
CY2022	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1746000	usd
CY2020	us-gaap	Advertising Expense AdvertisingExpense	664000	cny
CY2021	us-gaap	Advertising Expense AdvertisingExpense	515000	cny
CY2021	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		cny
CY2022	us-gaap	Advertising Expense AdvertisingExpense	423000	cny
CY2022	us-gaap	Advertising Expense AdvertisingExpense	61000	usd
CY2020	us-gaap	Income Tax Expense Benefit Continuing Operations Government Grants IncomeTaxExpenseBenefitContinuingOperationsGovernmentGrants	7541000	cny
CY2021	us-gaap	Income Tax Expense Benefit Continuing Operations Government Grants IncomeTaxExpenseBenefitContinuingOperationsGovernmentGrants	565000	cny
CY2022	us-gaap	Income Tax Expense Benefit Continuing Operations Government Grants IncomeTaxExpenseBenefitContinuingOperationsGovernmentGrants	877000	cny
CY2022	us-gaap	Income Tax Expense Benefit Continuing Operations Government Grants IncomeTaxExpenseBenefitContinuingOperationsGovernmentGrants	127000	usd
CY2022	us-gaap	Lessor Sales Type Lease Description LessorSalesTypeLeaseDescription	(a) ownership is transferred to the lessee by the end of the lease term, (b) there is a bargain purchase option, (c) the lease term is at least 75% of the property’s estimated remaining economic life, or (d) the present value of the minimum lease payments at the beginning of the lease term is 90% or more of the fair value of the leased property to the lessor at the inception date.
CY2020	us-gaap	Other Expenses OtherExpenses	1645000	cny
CY2021	us-gaap	Other Expenses OtherExpenses	3884000	cny
CY2022	us-gaap	Other Expenses OtherExpenses	3897000	cny
CY2022	us-gaap	Other Expenses OtherExpenses	565000	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>(dd) Risks, Uncertainties and Concentrations</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">COVID-19</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Beginning in late 2019, an outbreak of a novel strain of coronavirus (COVID-19) first emerged in China and has spread globally. In March 2020, the World Health Organization (“WHO”) declared COVID-19 as a pandemic. Governments in affected countries imposed travel bans, quarantines and other emergency public health measures, which caused material disruption to businesses globally resulting in an economic slowdown.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A new COVID-19 subvariant (Omicron) outbreak hit China in March 2022, spreading more quickly and easily than previous strains. As a result, a new round of lockdowns, quarantines, and travel restrictions were imposed upon different provinces or cities in China by the relevant local government authorities. The Company temporarily closed its Shanghai office and suspended offline marketing activities on April 1, 2022 as well. As required by the local authorities in Shanghai, employees located in Shanghai worked remotely. Beginning June 1, 2022, the Company reopened its Shanghai office and resumed offline marketing activities. For the year ended December 31, 2022, the COVID-19 pandemic had an adverse impact on the Company’s financial positions and operating results. For the year ended December 31, 2022, the Company’s revenue decreased to RMB12,044 (US$1,746) from RMB17,986 for the year ended December 31, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Starting in December 2022, China announced an easing of its COVID-19 restriction policy. Authorities downgraded the management of COVID-19 from category A to category B and lifted the restriction measures related to the COVID-19 pandemic, such as the reduction in travel and tourists, conventions and business events, closures and restrictions on business operations. The reopening of China’s economy from the stringent COVID-19 restrictions is expected to boost economic growth in Asia and beyond, but management is unable at this time to determine the future impact of the COVID-19 pandemic on its future operations, financial condition, liquidity, and results of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Concentration of credit risk</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Group to significant concentration of credit risk consist primarily of cash and cash equivalents and accounts receivables. As of December 31, 2021 and 2022, the aggregate amounts of cash and cash equivalents of RMB4,237 and RMB1,626 (US$236), respectively, were held at major financial institutions located in the PRC and RMB5,014 and RMB244 (US$35), respectively, were deposited with major financial institutions located outside the PRC. Management believes that these financial institutions are of high credit quality and continually monitors the credit worthiness of these financial institutions. There is a RMB 500,000 deposit insurance limit for a legal entity’s aggregated balance at each PRC bank.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Accounts receivables, unsecured and denominated in RMB, are exposed to credit risk. As of December 31, 2021, two customers accounted for 43% and 12% of total accounts receivables, respectively. As of December 31, 2022, three customers accounted for 24%, 16% and 16% of total accounts receivables. The risk is mitigated by credit evaluations the Group performs on its customers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Business, customer, supplier, political and economic risks</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group is in the early stages of development of its e-commerce food-related business and has a limited operating history. The recently acquired operations are subject to all of the risks inherent in the initial expenses, challenges, complications, and delays frequently encountered in connection with the formation of any new business.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Group participates in a dynamic industry and believes that changes in any of the following areas could have a material adverse effect on the Group’s future financial position, results of operations or cash flows: changes in the overall demand for services; competitive pressures due to new entrants; advances and new trends in industry standards; changes in certain strategic relationships or customer relationships; regulatory considerations; intellectual property considerations; and risks associated with the Group’s ability to attract and retain employees necessary to support its growth. The Group’s operations could be also adversely affected by significant political, economic and social uncertainties in the PRC. The Group is also reliant on contract manufacturers that manufacture key components of its CDA device used in its diagnostic testing.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2020, the Group had two customers that accounted for 29% and 15% of total revenues, respectively. For the year ended December 31, 2021, the Group had three customers that accounted for 36%, 17% and 11% of total revenues, respectively. For the year ended December 31, 2022, the Group had five customers that accounted for 30%, 18%, 15%, 14% and 13% of total revenues, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2020, the Group had four suppliers that accounted for 17%, 14%, 13% and 11% of total cost of revenues, respectively. For the year ended December 31, 2021, the Group had three suppliers that accounted for 11%, 11% and 10% of total cost of revenues, respectively. For the year ended December 31, 2022, the Group had four suppliers that accounted for 17%, 13%, 12% and 10% of total cost of revenues, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2021, four suppliers accounted for 22%, 13%, 12%and 12% of total accounts payables, respectively. As of December 31, 2022, one supplier accounted for 50% of total accounts payables, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currency convertibility risk</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A significant portion of the Group’s expenses, assets and liabilities are denominated in RMB. On January 1, 1994, the PRC government abolished the dual rate system and introduced a single rate of exchange as quoted daily by the People’s Bank of China (the “PBOC”). However, the unification of the exchange rates does not imply that the RMB may be readily convertible into U.S. dollar or other foreign currencies. All foreign exchange transactions continue to take place either through the PBOC or other banks authorized to buy and sell foreign currencies at the exchange rates quoted by the PBOC. Approvals of foreign currency payments by the PBOC or other institutions require submitting a payment application form together with relevant documents.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, the value of the RMB is subject to changes in central government policies and international economic and political developments affecting supply and demand in the PRC foreign exchange trading system market.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Foreign currency exchange rate risk</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From July 21, 2005, the RMB is permitted to fluctuate within a narrow and managed band against a basket of certain foreign currencies. For U.S. dollar against RMB, there was depreciation of 6.3%, appreciation of 2.3% and depreciation of 8.2% in the years ended December 31, 2020, 2021 and 2022, respectively. It is difficult to predict how market forces or PRC or the U.S. government policy may impact the exchange rate between the RMB and the U.S. dollar in the future.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The functional currency and the reporting currency of the Company and AnPac US are the US$ and the RMB, respectively. Most of the revenues and costs of the Group are denominated in RMB, while a portion of cash and cash equivalents and convertible loans (“CL”) are denominated in US$. It is difficult to predict how market forces or PRC or the U.S. government policy may impact the exchange rate between the Renminbi and the US$ in the future. Any significant fluctuation of the valuation of RMB may materially affect the Group’s cash flows, revenues, earnings and financial position, and the value of any dividends payable on the ADS in US$.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Deferred Revenue Period Increase Decrease DeferredRevenuePeriodIncreaseDecrease	12044000	cny
CY2022	us-gaap	Deferred Revenue Period Increase Decrease DeferredRevenuePeriodIncreaseDecrease	1746000	usd
CY2021	us-gaap	Deferred Revenue Period Increase Decrease DeferredRevenuePeriodIncreaseDecrease	17986000	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	4237000	cny
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1626000	cny
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	236000	usd
CY2021Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	5014000	cny
CY2022Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	244000	cny
CY2022Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	35000	usd
CY2022Q4	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	500000000	cny
CY2021	anpc	Total Accounts Payable Percent TotalAccountsPayablePercent	0.01	pure
CY2020	anpc	Depreciation Percent DepreciationPercent	0.063	pure
CY2021	anpc	Appreciation Percentage AppreciationPercentage	0.023	pure
CY2021Q3	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	8500000	cny
CY2021Q3	us-gaap	Deferred Policy Acquisition Cost Unrealized Investment Gain Loss DeferredPolicyAcquisitionCostUnrealizedInvestmentGainLoss	3240000	cny
CY2021Q3	anpc	Investment Percentage1 InvestmentPercentage1	0.20	pure
CY2021Q3	anpc	Ads Shares ADSShares	250000	shares
CY2021Q3	anpc	Agreement Cost AgreementCost	945000	usd
CY2021Q3	anpc	Agreement Cost AgreementCost	6105000	cny
CY2021Q3	us-gaap	Long Term Purchase Commitment Amount LongTermPurchaseCommitmentAmount	8500000	cny
CY2021Q3	us-gaap	Capital Units Net Amount CapitalUnitsNetAmount	2395000	cny
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	106395	shares
CY2021Q3	us-gaap-sup	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	3.49
CY2022Q4	anpc	Cash Acquired CashAcquired	41000	cny
CY2022Q4	anpc	Cash Acquired CashAcquired	6000	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	196000	cny
CY2022Q4	us-gaap	Other Receivables OtherReceivables	31000	usd
CY2022Q4	anpc	Current Assets CurrentAssets	237000	cny
CY2022Q4	anpc	Current Assets CurrentAssets	37000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Owned Net PropertyPlantAndEquipmentOwnedNet	420000	cny
CY2022Q4	us-gaap	Property Plant And Equipment Owned Net PropertyPlantAndEquipmentOwnedNet	66000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	9170000	cny
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1439000	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	12758000	cny
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	2002000	usd
CY2022Q4	us-gaap	Assets Net AssetsNet	22585000	cny
CY2022Q4	us-gaap	Assets Net AssetsNet	3544000	usd
CY2022Q4	anpc	Current Liabilities CurrentLiabilities	1472000	cny
CY2022Q4	anpc	Current Liabilities CurrentLiabilities	231000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2293000	cny
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	360000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	3765000	cny
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	591000	usd
CY2021Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	12977000	cny
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	13293000	cny
CY2022	anpc	Equity Value EquityValue	0.20	pure
CY2022	anpc	Equity Value EquityValue	0.20	pure
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	3440000	cny
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	540000	usd
CY2022	anpc	Equity Value With Noncontrolling Interest1 EquityValueWithNoncontrollingInterest1	0.40	pure
CY2022	anpc	Equity Value With Noncontrolling Interest1 EquityValueWithNoncontrollingInterest1	0.40	pure
CY2022Q4	anpc	Equity Value With Noncontrolling Interest EquityValueWithNoncontrollingInterest	6880000	cny
CY2022Q4	anpc	Equity Value With Noncontrolling Interest EquityValueWithNoncontrollingInterest	1080000	usd
CY2022Q4	anpc	Total Consideration Of Equity Value1 TotalConsiderationOfEquityValue1	0.40	pure
CY2022Q4	anpc	Total Consideration Of Equity Value1 TotalConsiderationOfEquityValue1	0.40	pure
CY2022Q4	anpc	Total Consideration Of Equity Value TotalConsiderationOfEquityValue	8500000	cny
CY2022Q4	anpc	Total Consideration Of Equity Value TotalConsiderationOfEquityValue	1333000	usd
CY2022	anpc	Amortization Over Year AmortizationOverYear	P6Y4M24D
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	6699000	cny
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3803000	cny
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	551000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1145000	cny
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1568000	cny
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	227000	usd
CY2021Q4	us-gaap	Trade Receivables Held For Sale Amount TradeReceivablesHeldForSaleAmount	5554000	cny
CY2022Q4	us-gaap	Trade Receivables Held For Sale Amount TradeReceivablesHeldForSaleAmount	2235000	cny
CY2022Q4	us-gaap	Trade Receivables Held For Sale Amount TradeReceivablesHeldForSaleAmount	324000	usd
CY2019Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	177000	cny
CY2020Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	304000	cny
CY2021Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	1145000	cny
CY2021Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	166000	usd
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	758000	cny
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	841000	cny
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	423000	cny
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	61000	usd
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	631000	cny
CY2020Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	304000	cny
CY2021Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	1145000	cny
CY2022Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	1568000	cny
CY2022Q4	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	227000	usd
CY2021Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	1853000	cny
CY2022Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	1696000	cny
CY2022Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	246000	usd
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	2053000	cny
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	2336000	cny
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	339000	usd
CY2021Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	3906000	cny
CY2022Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	4032000	cny
CY2022Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	585000	usd
CY2021Q4	us-gaap	Premiums Receivable Allowance For Doubtful Accounts PremiumsReceivableAllowanceForDoubtfulAccounts	556000	cny
CY2022Q4	us-gaap	Premiums Receivable Allowance For Doubtful Accounts PremiumsReceivableAllowanceForDoubtfulAccounts	584000	cny
CY2022Q4	us-gaap	Premiums Receivable Allowance For Doubtful Accounts PremiumsReceivableAllowanceForDoubtfulAccounts	85000	usd
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	3350000	cny
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	3448000	cny
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	500000	usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		cny
CY2019Q4	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYield	3000	cny
CY2020Q4	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYield	99000	cny
CY2021Q4	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYield	556000	cny
CY2021Q4	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYield	81000	usd
CY2020	anpc	Other Receivable Allowance For Credit Loss Expense OtherReceivableAllowanceForCreditLossExpense	96000	cny
CY2021	anpc	Other Receivable Allowance For Credit Loss Expense OtherReceivableAllowanceForCreditLossExpense	457000	cny
CY2022	anpc	Other Receivable Allowance For Credit Loss Expense OtherReceivableAllowanceForCreditLossExpense	-5000	cny
CY2022	anpc	Other Receivable Allowance For Credit Loss Expense OtherReceivableAllowanceForCreditLossExpense	-1000	usd
CY2022	us-gaap	Exchange Fees ExchangeFees	33000	cny
CY2022	us-gaap	Exchange Fees ExchangeFees	5000	usd
CY2020Q4	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYield	99000	cny
CY2021Q4	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYield	556000	cny
CY2022Q4	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYield	584000	cny
CY2022Q4	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYield	85000	usd
CY2021Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	16029000	cny
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	16029000	cny
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	2324000	usd
CY2021Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	1448000	cny
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1927000	usd
CY2021Q4	anpc	Motor Vehicles MotorVehicles	512000	cny
CY2022Q4	anpc	Motor Vehicles MotorVehicles	529000	cny
CY2022Q4	anpc	Motor Vehicles MotorVehicles	77000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	30966000	cny
CY2022Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	29851000	cny
CY2022Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	4328000	usd
CY2021Q4	anpc	Accumulated Depreciation AccumulatedDepreciation	12715000	cny
CY2022Q4	anpc	Accumulated Depreciation AccumulatedDepreciation	14600000	cny
CY2022Q4	anpc	Accumulated Depreciation AccumulatedDepreciation	2117000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	18251000	cny
CY2022Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	15251000	cny
CY2022Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	2211000	usd
CY2021Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	2013000	cny
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	1931000	cny
CY2022Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	280000	usd
CY2021Q4	us-gaap	Public Utilities Property Plant And Equipment Net PublicUtilitiesPropertyPlantAndEquipmentNet	20264000	cny
CY2022Q4	us-gaap	Public Utilities Property Plant And Equipment Net PublicUtilitiesPropertyPlantAndEquipmentNet	17182000	cny
CY2022Q4	us-gaap	Public Utilities Property Plant And Equipment Net PublicUtilitiesPropertyPlantAndEquipmentNet	2491000	usd
CY2020	us-gaap	Depreciation Depreciation	2441000	cny
CY2021	us-gaap	Depreciation Depreciation	2727000	cny
CY2022	us-gaap	Depreciation Depreciation	3781000	cny
CY2022	us-gaap	Depreciation Depreciation	548000	usd
CY2021Q4	us-gaap	Land Land	1388000	cny
CY2022Q4	us-gaap	Land Land	1388000	cny
CY2022Q4	us-gaap	Land Land	201000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	250000	cny
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	277000	cny
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	40000	usd
CY2021Q4	anpc	Land Use Rights Net LandUseRightsNet	1138000	cny
CY2022Q4	anpc	Land Use Rights Net LandUseRightsNet	1111000	cny
CY2022Q4	anpc	Land Use Rights Net LandUseRightsNet	161000	usd
CY2020	us-gaap	Amortization Of Rate Deferral AmortizationOfRateDeferral	28000	cny
CY2022	us-gaap	Amortization Of Rate Deferral AmortizationOfRateDeferral	28000	cny
CY2021	us-gaap	Amortization Of Rate Deferral AmortizationOfRateDeferral	28000	cny
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		cny
CY2022	us-gaap	Amortization Of Rate Deferral AmortizationOfRateDeferral	4000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15767000	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15902000	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2306000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1610000	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1247000	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-181000	usd
CY2021Q4	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	5300000	cny
CY2022Q4	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	14470000	cny
CY2022Q4	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	2098000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8857000	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	185000	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27000	usd
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	630000	cny
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1155000	cny
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	895000	cny
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	130000	usd
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	7911000	cny
CY2022Q4	anpc	Deferred Lease Income Before Accumulated Amortisation DeferredLeaseIncomeBeforeAccumulatedAmortisation	9170000	cny
CY2022Q4	anpc	Deferred Lease Income After Accumulated Amortisation DeferredLeaseIncomeAfterAccumulatedAmortisation	1259000	cny
CY2022	anpc	Estimated Aggregate Amortization Expense Years EstimatedAggregateAmortizationExpenseYears	P5Y
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	49000	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	48000	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	14000	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	14000	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	14000	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	46000	cny
CY2022Q4	anpc	Finite Lived Intangible Asset Net FiniteLivedIntangibleAssetNet	185000	cny
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		cny
CY2021Q1	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	1000	usd
CY2021Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	563800	shares
CY2021Q1	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	16176000	cny
CY2021Q4	anpc	Impairmentoflongterminvestment Impairmentoflongterminvestment	2750000	cny
CY2022Q4	anpc	Impairmentoflongterminvestment Impairmentoflongterminvestment	2750000	cny
CY2022Q4	anpc	Impairmentoflongterminvestment Impairmentoflongterminvestment	399000	usd
CY2021Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	923000	cny
CY2022Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	1079000	cny
CY2022Q4	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	156000	usd
CY2016Q1	anpc	Investment Percentage InvestmentPercentage	0.10	pure
CY2017Q4	us-gaap	Discontinued Operation Equity Method Investment Retained After Disposal Ownership Interest After Disposal DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal	0.05	pure
CY2020	anpc	Full Impairment Loss FullImpairmentLoss	1430000	cny
CY2021Q4	anpc	Shortterm Bank And Other Borrowings ShorttermBankAndOtherBorrowings	5900000	cny
CY2022Q4	anpc	Shortterm Bank And Other Borrowings ShorttermBankAndOtherBorrowings	5000000	cny
CY2022Q4	anpc	Shortterm Bank And Other Borrowings ShorttermBankAndOtherBorrowings	725000	usd
CY2021Q4	anpc	Convertible Loan ConvertibleLoan	27859000	cny
CY2022Q4	anpc	Convertible Loan ConvertibleLoan	15000	cny
CY2022Q4	anpc	Convertible Loan ConvertibleLoan	2000	usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	33759000	cny
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	5015000	cny
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	727000	usd
CY2022Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	5000000	cny
CY2022	us-gaap	Short Term Debt Interest Rate Increase ShortTermDebtInterestRateIncrease	0.036	pure
CY2021Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	5900000	cny
CY2021	us-gaap	Short Term Debt Interest Rate Increase ShortTermDebtInterestRateIncrease	0.0435	pure
CY2022Q4	us-gaap	Retail Land Sales Deposit Method Property Carrying Value RetailLandSalesDepositMethodPropertyCarryingValue	11325000	cny
CY2022Q4	us-gaap	Retail Land Sales Deposit Method Property Carrying Value RetailLandSalesDepositMethodPropertyCarryingValue	1642000	usd
CY2020	us-gaap	Interest Expense InterestExpense	728000	cny
CY2021	us-gaap	Interest Expense InterestExpense	238000	cny
CY2022	us-gaap	Interest Expense InterestExpense	236000	cny
CY2022	us-gaap	Interest Expense InterestExpense	34000	usd
CY2020Q3	us-gaap	Convertible Debt ConvertibleDebt	1689000	cny
CY2020Q3	us-gaap	Short Term Debt Percentage Bearing Variable Interest Rate ShortTermDebtPercentageBearingVariableInterestRate	0.10	pure
CY2021Q1	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	54642	shares
CY2020Q3	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	2283000	cny
CY2021Q1	us-gaap	Convertible Debt ConvertibleDebt	12745000	cny
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		cny
CY2021Q2	us-gaap	Convertible Debt ConvertibleDebt	4479000	cny
CY2021Q1	us-gaap	Short Term Debt Percentage Bearing Variable Interest Rate ShortTermDebtPercentageBearingVariableInterestRate	0	pure
CY2021Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	15000	usd
CY2021Q1	anpc	Bidding Price Percentage BiddingPricePercentage	0.82	pure
CY2021Q1	us-gaap	Short Term Debt Weighted Average Interest Rate Over Time ShortTermDebtWeightedAverageInterestRateOverTime	0.80	pure
CY2021Q2	us-gaap	Short Term Debt Percentage Bearing Variable Interest Rate ShortTermDebtPercentageBearingVariableInterestRate	0	pure
CY2021Q2	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	15000	usd
CY2021Q2	anpc	Bidding Price Percentage BiddingPricePercentage	0.82	pure
CY2021Q2	us-gaap	Short Term Debt Weighted Average Interest Rate Over Time ShortTermDebtWeightedAverageInterestRateOverTime	0.80	pure
CY2021Q2	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	1000	usd
CY2022Q1	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.1
CY2021Q2	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	5502000	cny
CY2021Q3	us-gaap	Convertible Debt ConvertibleDebt	3014000	usd
CY2021Q3	us-gaap	Convertible Debt ConvertibleDebt	20788000	cny
CY2021Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	2740000	usd
CY2021Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	18898000	cny
CY2021Q3	us-gaap	Short Term Debt Percentage Bearing Variable Interest Rate ShortTermDebtPercentageBearingVariableInterestRate	0	pure
CY2021Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	15000	usd
CY2021Q3	anpc	Bidding Price Percentage BiddingPricePercentage	0.82	pure
CY2021Q3	us-gaap	Short Term Debt Weighted Average Interest Rate Over Time ShortTermDebtWeightedAverageInterestRateOverTime	0.80	pure
CY2021Q3	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	1000	usd
CY2021Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	114234	shares
CY2021Q3	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	1321000	cny
CY2022Q1	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	22237000	cny
CY2022Q1	anpc	Convertible Debentures ConvertibleDebentures	15000	cny
CY2022Q1	anpc	Convertible Debentures ConvertibleDebentures	2000	usd
CY2020	us-gaap-sup	Unrealized Gain Loss Security Sold Short Operating UnrealizedGainLossSecuritySoldShortOperating	6630000	cny
CY2021	us-gaap-sup	Unrealized Gain Loss Security Sold Short Operating UnrealizedGainLossSecuritySoldShortOperating	9073000	cny
CY2022	us-gaap-sup	Unrealized Gain Loss Security Sold Short Operating UnrealizedGainLossSecuritySoldShortOperating	144000	cny
CY2022	us-gaap-sup	Unrealized Gain Loss Security Sold Short Operating UnrealizedGainLossSecuritySoldShortOperating	21000	usd
CY2020	us-gaap	Interest Expense Other InterestExpenseOther	451000	cny
CY2021	us-gaap	Interest Expense Other InterestExpenseOther	3797000	cny
CY2020	us-gaap	Short Term Debt Weighted Average Interest Rate Over Time ShortTermDebtWeightedAverageInterestRateOverTime	0.084	pure
CY2021	us-gaap	Short Term Debt Weighted Average Interest Rate Over Time ShortTermDebtWeightedAverageInterestRateOverTime	0.0397	pure
CY2022	us-gaap	Short Term Debt Weighted Average Interest Rate Over Time ShortTermDebtWeightedAverageInterestRateOverTime	0.0277	pure
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7213000	cny
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1046000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	784000	cny
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	114000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6515000	cny
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	945000	usd
CY2022Q4	anpc	Operating Lease Liabilities OperatingLeaseLiabilities	7299000	cny
CY2022Q4	anpc	Operating Lease Liabilities OperatingLeaseLiabilities	1059000	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		cny
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y5M1D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0435	pure
CY2022Q4	anpc	Operating Leases Future Minimum Payment Due Current OperatingLeasesFutureMinimumPaymentDueCurrent	1080000	cny
CY2022Q4	anpc	Operating Leases Future Minimum Payment Due In Two Years OperatingLeasesFutureMinimumPaymentDueInTwoYears	1103000	cny
CY2022Q4	anpc	Operating Leases Future Minimum Payment Due In Three Years OperatingLeasesFutureMinimumPaymentDueInThreeYears	1127000	cny
CY2022Q4	anpc	Operating Leases Future Minimum Payment Due In Four Years OperatingLeasesFutureMinimumPaymentDueInFourYears	1150000	cny
CY2022Q4	anpc	Operating Leases Future Minimum Payment Due In Five Years OperatingLeasesFutureMinimumPaymentDueInFiveYears	1173000	cny
CY2022Q4	anpc	Operating Leases Future Minimum Payment Due In Six Years OperatingLeasesFutureMinimumPaymentDueInSixYears	1196000	cny
CY2022Q4	anpc	Operating Leases Future Minimum Payment Due Thereafter OperatingLeasesFutureMinimumPaymentDueThereafter	1732000	cny
CY2022Q4	anpc	Operating Leases Future Minimum Payment Due OperatingLeasesFutureMinimumPaymentDue	8561000	cny
CY2022Q4	us-gaap	Receivable With Imputed Interest Net Amount ReceivableWithImputedInterestNetAmount	1262000	cny
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7299000	cny
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8101000	cny
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12803000	cny
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1856000	usd
CY2021Q4	anpc	Payable For Acquisition Of Noncontrolling Interests PayableForAcquisitionOfNoncontrollingInterests	245000	cny
CY2022Q4	anpc	Payable For Acquisition Of Noncontrolling Interests PayableForAcquisitionOfNoncontrollingInterests	245000	cny
CY2022Q4	anpc	Payable For Acquisition Of Noncontrolling Interests PayableForAcquisitionOfNoncontrollingInterests	36000	usd
CY2021Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	1140000	cny
CY2022Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	1244000	cny
CY2020	anpc	Forgivenesses Of Ppp Loan ForgivenessesOfPPPLoan		cny
CY2022Q4	us-gaap	Accrued Rent Current AccruedRentCurrent	180000	usd
CY2021Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	417000	cny
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	359000	cny
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	52000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	71000	cny
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	46000	cny
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	7000	usd
CY2021Q4	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	58000	cny
CY2022Q4	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	41000	cny
CY2022Q4	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	6000	usd
CY2021Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1564000	cny
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	1011000	cny
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	146000	usd
CY2021Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	19770000	cny
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	25921000	cny
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	3758000	usd
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2020Q1	us-gaap	Stockholders Equity Other Shares StockholdersEquityOtherShares	1333360	shares
CY2020Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	12
CY2022	anpc	Net Proceeds NetProceeds	35200000	cny
CY2022	anpc	Net Proceeds NetProceeds	5395000	usd
CY2022Q4	us-gaap	Preferred Units Offering Costs PreferredUnitsOfferingCosts	75460000	cny
CY2022Q4	us-gaap	Preferred Units Offering Costs PreferredUnitsOfferingCosts	11565000	usd
CY2021Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1689000	cny
CY2021Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	5120	usd
CY2021Q2	us-gaap	Limited Liability Company Llc Preferred Unit Issued LimitedLiabilityCompanyLLCPreferredUnitIssued	563800	shares
CY2021Q2	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	12745000	cny
CY2021Q4	anpc	Convertible Debentures ConvertibleDebentures	1000	cny
CY2022Q1	us-gaap	Limited Liability Company Llc Preferred Unit Issued LimitedLiabilityCompanyLLCPreferredUnitIssued	4842197	shares
CY2022Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	5502000	cny
CY2022Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	839000	usd
CY2020Q3	us-gaap	Share Based Goods And Nonemployee Services Transaction Shares Approved For Issuance ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance	70000	shares
CY2020Q3	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	2706000	cny
CY2023Q2	anpc	Service Agreement Pay ServiceAgreementPay	50000	usd
CY2022Q2	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	359000	cny
CY2022Q2	us-gaap	Assets Fair Value Adjustment AssetsFairValueAdjustment	54000	usd
CY2021Q3	anpc	Fair Market Value fairMarketValue	3490	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	5694000	usd
CY2022Q3	anpc	Fair Market Value fairMarketValue	1341000	cny
CY2022Q3	anpc	Fair Market Value fairMarketValue	195000	usd
CY2022Q1	anpc	Convertible Debt convertibleDebt	8807270	shares
CY2021Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	152100	shares
CY2021Q1	us-gaap	Sale Leaseback Transaction Gross Proceeds Financing Activities SaleLeasebackTransactionGrossProceedsFinancingActivities	12000000	cny
CY2021Q1	us-gaap	Sale Leaseback Transaction Gross Proceeds Financing Activities SaleLeasebackTransactionGrossProceedsFinancingActivities	1883000	usd
CY2021Q3	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	250000	shares
CY2021Q3	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	6105000	cny
CY2021Q3	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	945000	usd
CY2021Q3	anpc	Agreement Net Amount AgreementNetAmount	2395000	cny
CY2021Q3	anpc	Agreement Net Amount AgreementNetAmount	376000	usd
CY2022	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	0.00001
CY2022Q2	us-gaap	Investment Income Net InvestmentIncomeNet	20094000	cny
CY2022Q2	us-gaap	Investment Income Net InvestmentIncomeNet	3000000	usd
CY2022Q2	us-gaap	Share Price SharePrice	0.3
CY2022Q2	anpc	Trading Price Percentage TradingPricePercentage	0.80	pure
CY2022Q4	anpc	Purchase Of Aggregate Shares PurchaseOfAggregateShares	1200000	shares
CY2022Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.75
CY2022Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	1507000	usd
CY2022Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	5000000	shares
CY2022Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.1
CY2022Q3	anpc	Sharebase Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 sharebaseCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y
CY2022Q3	anpc	Gross Proceeds GrossProceeds	3613000	cny
CY2022Q3	anpc	Gross Proceeds GrossProceeds	500000	usd
CY2022Q3	anpc	Gross Proceeds GrossProceeds	26410000	cny
CY2022Q3	anpc	Gross Proceeds GrossProceeds	3660000	usd
CY2022	anpc	Warrant Outstanding WarrantOutstanding	9226135	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	9226135	shares
CY2022	us-gaap	Partners Capital Account Units Sold In Private Placement PartnersCapitalAccountUnitsSoldInPrivatePlacement	40000	shares
CY2022Q4	anpc	Fair Market Value fairMarketValue	2000	cny
CY2022Q4	anpc	Fair Market Value fairMarketValue	0	usd
CY2021	anpc	Connection With Private Placement ConnectionWithPrivatePlacement	4226135	shares
CY2021	anpc	Share Warrants Issued In Connection ShareWarrantsIssuedInConnection	0.00001
CY2021	anpc	Expiration Dates Warrants Issued In Connectio Private Placement ExpirationDatesWarrantsIssuedInConnectioPrivatePlacement	Unlimited
CY2021	anpc	Number Of Warrants Warrants Issued Connection With Private Placement NumberOfWarrantsWarrantsIssuedConnectionWithPrivatePlacement	5000000	shares
CY2021	anpc	Weighted Average Exercise Price Per Share Warrants Issued In Connection WeightedAverageExercisePricePerShareWarrantsIssuedInConnection	0.4
CY2021	anpc	Weighted Average Life Warrants Issued In Connection With Private Placementterm WeightedAverageLifeWarrantsIssuedInConnectionWithPrivatePlacementterm	P1Y10M6D
CY2021	anpc	Warrants Issued In Connection With Private Placement WarrantsIssuedInConnectionWithPrivatePlacement	November 6, 2024
CY2021	anpc	Number Of Warrants Warrants Issued To3rd Party Service Providers NumberOfWarrantsWarrantsIssuedTo3rdPartyServiceProviders	40000	shares
CY2021	anpc	Weighted Average Exercise Price Per Share Warrants Issued To3rd Party Service Providers WeightedAverageExercisePricePerShareWarrantsIssuedTo3rdPartyServiceProviders	6
CY2021	anpc	Weighted Average Life Warrants Issued To3rd Party Service Providersterm WeightedAverageLifeWarrantsIssuedTo3rdPartyServiceProvidersterm	P1Y8M1D
CY2021	anpc	Warrants Issued To3rd Party Service Providersdates WarrantsIssuedTo3rdPartyServiceProvidersdates	August 31, 2024
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	9266135	shares
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	0.24
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y10M6D
CY2021	anpc	Expiration Dates Balance Of Warrants Outstanding And Exercisable ExpirationDatesBalanceOfWarrantsOutstandingAndExercisable	August 31, 2024 to unlimited
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Number Of Shares Period Increase Decrease SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNumberOfSharesPeriodIncreaseDecrease	4700000	shares
CY2022	anpc	Granted To Employees Year Term GrantedToEmployeesYearTerm	P4Y
CY2022	us-gaap	Incremental Common Shares Attributable To Written Put Options IncrementalCommonSharesAttributableToWrittenPutOptions	182593	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0003
CY2023Q1	anpc	Options Purchase OptionsPurchase	4000000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	916500	shares
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	7480
CY2019Q4	anpc	Weighted Average Remaining Contractual Term Outstanding Beginning Balance WeightedAverageRemainingContractualTermOutstandingBeginningBalance	P7Y3M3D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	8985000	usd
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	379000	shares
CY2020	anpc	Weighted Average Exercise Price Granted WeightedAverageExercisePriceGranted	9.07
CY2020	anpc	Weighted Average Grant Date Fair Value Granted WeightedAverageGrantDateFairValueGranted	3100
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	213700	shares
CY2020	anpc	Weighted Average Grant Date Fair Value Exercised WeightedAverageGrantDateFairValueExercised	8130
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	30000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.0001
CY2020	anpc	Weighted Average Grant Date Fair Value Forfeitedin Shares WeightedAverageGrantDateFairValueForfeitedinShares	3040.00
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1051800	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.27
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	5870
CY2020	anpc	Weighted Average Remaining Contractual Term Outstanding Ending Balance WeightedAverageRemainingContractualTermOutstandingEndingBalance	P7Y4M13D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	3616000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	552814	shares
CY2021	anpc	Weighted Average Exercise Price Granted WeightedAverageExercisePriceGranted	2.49
CY2021	anpc	Weighted Average Grant Date Fair Value Granted WeightedAverageGrantDateFairValueGranted	3470
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	544014	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1060600	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.65
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	4910
CY2021	anpc	Weighted Average Remaining Contractual Term Outstanding Ending Balance WeightedAverageRemainingContractualTermOutstandingEndingBalance	P7Y25D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	637000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2262322	shares
CY2022	anpc	Weighted Average Exercise Price Granted WeightedAverageExercisePriceGranted	0.53
CY2022	anpc	Weighted Average Grant Date Fair Value Granted WeightedAverageGrantDateFairValueGranted	860
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	988016	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2334906	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.69
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	5080.00
CY2022	anpc	Weighted Average Remaining Contractual Term Outstanding Ending Balance WeightedAverageRemainingContractualTermOutstandingEndingBalance	P8Y18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	452000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	2128656	shares
CY2022	anpc	Weighted Average Exercise Price Vested And Exercisable WeightedAverageExercisePriceVestedAndExercisable	1.32
CY2022	anpc	Weighted Average Grant Date Fair Value Vested And Exercisable WeightedAverageGrantDateFairValueVestedAndExercisable	2020.00
CY2022	anpc	Weighted Average Remaining Contractual Term Vested And Exercisable WeightedAverageRemainingContractualTermVestedAndExercisable	P8Y25D
CY2022	anpc	Aggregate Intrinsic Value Vested And Exercisable AggregateIntrinsicValueVestedAndExercisable	444000	usd
CY2022	anpc	Forgivenesses Of Ppp Loan ForgivenessesOfPPPLoan		cny
CY2020	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	327000	cny
CY2021	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	305000	cny
CY2022	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	1000	cny
CY2020	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	1113000	cny
CY2021	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	3523000	cny
CY2022	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	2947000	cny
CY2022	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	427000	usd
CY2020	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	3534000	cny
CY2021	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	7366000	cny
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	4724000	cny
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	685000	usd
CY2020	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	12788000	cny
CY2021	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	22973000	cny
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	7252000	cny
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1052000	usd
CY2020	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	17762000	cny
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	34167000	cny
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	14924000	cny
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2164000	usd
CY2020	us-gaap	Dividend Income Securities Operating Taxable DividendIncomeSecuritiesOperatingTaxable	1000000	cny
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.125	pure
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.20	pure
CY2021	us-gaap	Dividend Income Securities Operating Taxable DividendIncomeSecuritiesOperatingTaxable	1000000	cny
CY2021	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	3000000	cny
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.50	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.20	pure
CY2022	us-gaap	Dividend Income Securities Operating Taxable DividendIncomeSecuritiesOperatingTaxable	1000000	cny
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.125	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.20	pure
CY2022	anpc	Preferential Income Tax Rate Percentage PreferentialIncomeTaxRatePercentage	0.15	pure
CY2022	anpc	Withholding Tax Rate Percentage WithholdingTaxRatePercentage	0.10	pure
CY2020	anpc	Effectve Corporate Income Tax Rate Percentage EffectveCorporateIncomeTaxRatePercentage	0.21	pure
CY2021	anpc	Effectve Corporate Income Tax Rate Percentage EffectveCorporateIncomeTaxRatePercentage	0.21	pure
CY2022	anpc	Effectve Corporate Income Tax Rate Percentage EffectveCorporateIncomeTaxRatePercentage	0.21	pure
CY2020	anpc	Effective Income Tax Rate Reconciliation Preferential Income Tax Rate Differential Amount EffectiveIncomeTaxRateReconciliationPreferentialIncomeTaxRateDifferentialAmount	-552000	cny
CY2022	anpc	Forgivenesses Of Ppp Loan ForgivenessesOfPPPLoan		usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-13440000	cny
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-80653000	cny
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-121267000	cny
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-1949000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	28000	cny
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4000	usd
CY2020	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	88000	cny
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	1180000	cny
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	2158000	cny
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	313000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	88000	cny
CY2021	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	1180000	cny
CY2022	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	2130000	cny
CY2022	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	309000	usd
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2020	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-80653000	cny
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-121267000	cny
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-105728000	cny
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-15328000	usd
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	20163000	cny
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	30317000	cny
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	26432000	cny
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	3832000	usd
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	2475000	cny
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-538000	cny
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-6109000	cny
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-886000	usd
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-9606000	cny
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-18708000	cny
CY2021	anpc	Effective Income Tax Rate Reconciliation Preferential Income Tax Rate Differential Amount EffectiveIncomeTaxRateReconciliationPreferentialIncomeTaxRateDifferentialAmount	-1099000	cny
CY2022	anpc	Effective Income Tax Rate Reconciliation Preferential Income Tax Rate Differential Amount EffectiveIncomeTaxRateReconciliationPreferentialIncomeTaxRateDifferentialAmount	-938000	cny
CY2022	anpc	Effective Income Tax Rate Reconciliation Preferential Income Tax Rate Differential Amount EffectiveIncomeTaxRateReconciliationPreferentialIncomeTaxRateDifferentialAmount	-136000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-1967000	cny
CY2022	anpc	Effect Of Impairment Of Goodwill EffectOfImpairmentOfGoodwill	-3190000	cny
CY2022	anpc	Effect Of Impairment Of Goodwill EffectOfImpairmentOfGoodwill	-462000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1347000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	195000	usd
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-12392000	cny
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-6825000	cny
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	722000	cny
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	105000	usd
CY2020	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	88000	cny
CY2021	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	1180000	cny
CY2022	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	2130000	cny
CY2022	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	309000	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	40986000	cny
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	39451000	cny
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	5720000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	1460000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	2217000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	321000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1012000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1068000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	155000	usd
CY2021Q4	us-gaap	Tax Credit Carryforward Valuation Allowance TaxCreditCarryforwardValuationAllowance	43458000	cny
CY2022Q4	us-gaap	Tax Credit Carryforward Valuation Allowance TaxCreditCarryforwardValuationAllowance	42736000	cny
CY2022Q4	us-gaap	Tax Credit Carryforward Valuation Allowance TaxCreditCarryforwardValuationAllowance	6196000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2158000	cny
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	2158000	cny
CY2021Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	335000	cny
CY2022Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	2211000	cny
CY2022Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	320000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	135000	cny
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	17000	cny
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	2000	usd
CY2021Q4	us-gaap	Due From Related Parties DueFromRelatedParties	200000	cny
CY2022Q4	us-gaap	Due From Related Parties DueFromRelatedParties	2194000	cny
CY2022Q4	us-gaap	Due From Related Parties DueFromRelatedParties	318000	usd
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	2471000	cny
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	3494000	cny
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	507000	usd
CY2020	anpc	Rents From Shanghai Muqing Industrial RentsFromShanghaiMuqingIndustrial	-443000	cny
CY2021	anpc	Rents From Shanghai Muqing Industrial RentsFromShanghaiMuqingIndustrial	-411000	cny
CY2022	anpc	Rents From Shanghai Muqing Industrial RentsFromShanghaiMuqingIndustrial	32000	cny
CY2022	anpc	Rents From Shanghai Muqing Industrial RentsFromShanghaiMuqingIndustrial	5000	usd
CY2020Q4	anpc	Interest Expense To Jiaxing Zhijun InterestExpenseToJiaxingZhijun	1664000	cny
CY2021Q4	anpc	Interest Expense To Jiaxing Zhijun InterestExpenseToJiaxingZhijun	1935000	cny
CY2021	anpc	Issuance Shares For Stock Option Exercised By Dr Chris Chang IssuanceSharesForStockOptionExercisedByDrChrisChang	6125000	cny
CY2022	anpc	Issuance Shares For Stock Option Exercised By Dr Chris Chang IssuanceSharesForStockOptionExercisedByDrChrisChang	273000	cny
CY2022	anpc	Issuance Shares For Stock Option Exercised By Dr Chris Chang IssuanceSharesForStockOptionExercisedByDrChrisChang	40000	usd
CY2021	anpc	Issuance Shares For Settlement Off Related Party Loan IssuanceSharesForSettlementOffRelatedPartyLoan	6891000	cny
CY2021	anpc	Share Based Compensatio ShareBasedCompensatio	6430000	cny
CY2021	anpc	Repayment Of Loan To Jiaxing Zhijun RepaymentOfLoanToJiaxingZhijun	-300000	cny
CY2022	anpc	Foreign Invested Percentage ForeignInvestedPercentage	0.10	pure
CY2022	anpc	Annual Aftertax Profits AnnualAftertaxProfits	0.50	pure
CY2022	anpc	Net Profits Precentage NetProfitsPrecentage	0.10	pure
CY2021Q4	us-gaap	Net Regulatory Assets NetRegulatoryAssets	181934000	cny
CY2022Q4	us-gaap	Net Regulatory Assets NetRegulatoryAssets	212609000	cny
CY2022Q4	us-gaap	Net Regulatory Assets NetRegulatoryAssets	30825000	usd
CY2022	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	5805000	usd
CY2022	anpc	Investment Agreements Description InvestmentAgreementsDescription	Concurrently, for each Class A ordinary share purchased, the investors received two warrants with each warrant to purchase one Class A ordinary share at an exercise price of US$0.21 per ordinary share. The warrants are exercisable within 2 years from the date of issuance.
CY2022	dei	Entity Registrant Name EntityRegistrantName	Fresh2 Group Ltd
CY2022Q4	us-gaap	Goodwill Goodwill		cny
CY2022Q4	us-gaap	Goodwill Goodwill		usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet		cny
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet		usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		cny
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		cny
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		usd
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes		cny
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes		cny
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes		usd
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		cny
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		cny
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		cny
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		cny
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		cny
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		cny
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		cny
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		cny
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		cny
CY2020	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		cny
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		cny
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		cny
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		cny
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		cny
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2021	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering		cny
CY2022	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering		cny
CY2022	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering		usd
CY2020	anpc	Issuance Shares For Stock Option Exercised By Dr Chris Chang Yu IssuanceSharesForStockOptionExercisedByDrChrisChangYu		cny
CY2020	anpc	Issuance Shares For Related Party Loan IssuanceSharesForRelatedPartyLoan		cny
CY2022	anpc	Issuance Shares For Related Party Loan IssuanceSharesForRelatedPartyLoan		cny
CY2022	anpc	Issuance Shares For Related Party Loan IssuanceSharesForRelatedPartyLoan		usd
CY2020	us-gaap	Stock Issued1 StockIssued1		cny
CY2022	us-gaap	Stock Issued1 StockIssued1		cny
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2020	anpc	Reclassification Of Accounts Payable To Convertible Loan ReclassificationOfAccountsPayableToConvertibleLoan		cny
CY2022	anpc	Reclassification Of Accounts Payable To Convertible Loan ReclassificationOfAccountsPayableToConvertibleLoan		cny
CY2022	anpc	Reclassification Of Accounts Payable To Convertible Loan ReclassificationOfAccountsPayableToConvertibleLoan		usd
CY2020	anpc	Conversion Of Convertible Loans ConversionOfConvertibleLoans		cny
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		cny
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		cny
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues		cny
CY2022	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues		usd
CY2022	anpc	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Conversion Of Accounts Payable Issuances FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfAccountsPayableIssuances		cny
CY2022	anpc	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Conversion Of Accounts Payable Issuances FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionOfAccountsPayableIssuances		usd
CY2021	anpc	Recognized An Impairment On Its Equity Investment RecognizedAnImpairmentOnItsEquityInvestment		cny
CY2022	anpc	Recognized An Impairment On Its Equity Investment RecognizedAnImpairmentOnItsEquityInvestment		cny
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs		cny
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs		cny
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs		usd
CY2020	us-gaap	Exchange Fees ExchangeFees		cny
CY2021	us-gaap	Exchange Fees ExchangeFees		usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross		cny
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross		usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill Fair Value Disclosure IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure		usd
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss		usd
CY2021	anpc	Full Impairment Loss FullImpairmentLoss		usd
CY2022	anpc	Full Impairment Loss FullImpairmentLoss		usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber		shares
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms
CY2020	anpc	Weighted Average Remaining Contractual Term Granted WeightedAverageRemainingContractualTermGranted
CY2020	anpc	Aggregate Intrinsic Value Granted AggregateIntrinsicValueGranted		usd
CY2020	anpc	Weighted Average Exercise Price Exercised WeightedAverageExercisePriceExercised
CY2020	anpc	Weighted Average Remaining Contractual Term Exercised WeightedAverageRemainingContractualTermExercised
CY2020	anpc	Aggregate Intrinsic Value Exercised AggregateIntrinsicValueExercised		usd
CY2022	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold		usd
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		cny
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		cny
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		cny
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets		cny
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets		usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities		cny
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities		usd
CY2022Q4	anpc	Interest Expense To Jiaxing Zhijun InterestExpenseToJiaxingZhijun		cny
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001786511

Files In Submission

Name	View Source	Status
0001213900-23-040488-index-headers.html	Edgar Link	pending
0001213900-23-040488-index.html	Edgar Link	pending
0001213900-23-040488.txt	Edgar Link	pending
0001213900-23-040488-xbrl.zip	Edgar Link	pending
anpc-20221231.xsd	Edgar Link	pending
ex15-1_001.jpg	Edgar Link	pending
ex15-1_002.jpg	Edgar Link	pending
ex15-2_001.jpg	Edgar Link	pending
f20f2022ex12-1_fresh2group.htm	Edgar Link	pending
f20f2022ex12-2_fresh2group.htm	Edgar Link	pending
f20f2022ex13-1_fresh2group.htm	Edgar Link	pending
anpc-20221231_cal.xml	Edgar Link	unprocessable
anpc-20221231_def.xml	Edgar Link	unprocessable
anpc-20221231_pre.xml	Edgar Link	unprocessable
anpc-20221231_lab.xml	Edgar Link	unprocessable
f20f2022ex13-2_fresh2group.htm	Edgar Link	pending
f20f2022ex15-1_fresh2group.htm	Edgar Link	pending
f20f2022ex15-2_fresh2group.htm	Edgar Link	pending
f20f2022ex4-15_fresh2group.htm	Edgar Link	pending
f20f2022ex8-1_fresh2group.htm	Edgar Link	pending
f20f2022_fresh2group.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fin_001.jpg	Edgar Link	pending
fin_002.jpg	Edgar Link	pending
fin_003.jpg	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
f20f2022_fresh2group_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FRES
Fresh2 Group Ltd Stock $fres

2022 Q4 Form 20-F Financial Statement

#000121390023040488 Filed on May 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FRES Fresh2 Group Ltd Stock $fres

2022 Q4 Form 20-F Financial Statement

#000121390023040488 Filed on May 16, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FRES
Fresh2 Group Ltd Stock $fres